openPR Logo
Press release

Global Trigeminal Neuralgia (TN) Therapeutics Market

03-29-2017 01:48 PM CET | Health & Medicine

Press release from: Persistence Market Research Pvt. Ltd

Trigeminal neuralgia occurs when the functioning of the trigeminal nerve is disrupted due to damage of the nerve. Trigeminal neuralgia is a chronic condition resulting in intense and extreme pain in the face and is more common among females. The incident represents electrical shock-like feeling and lasts from few seconds to minutes. The etiology of trigeminal neuralgia includes compression of blood vessels, degeneration of arteries, myelin sheath infiltration and idiopathic. Trigeminal neuralgia is most commonly seen after the age of 40 years. Diagnosis of trigeminal neuralgia includes dental pathology diagnosis, temporal arteritis’ diagnosis, disorders of myelin diagnosis, tumor in posterior fossa diagnosis and migraine diagnosis. Treatment for trigeminal neuralgia includes anticonvulsants or painkiller drug and surgery. There are various types of surgical procedures available for trigeminal neuralgia such as rhizotomy, stereotactic radiosurgery, microvascular decompression, transcutaneous electrical nerve stimulation and acupuncture.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/5759

With the rising geriatric population the market for trigeminal neuralgia therapeutics is experiencing a significant growth worldwide as geriatrics are more prone to get this disease. Moreover, technological advancements in diagnostic tests and growing public awareness about the disease also drives the growth of trigeminal neuralgia therapeutics market globally. However, technical complexities associated with existing diagnostic tests and surgeries associated with trigeminal neuralgia might hinder the market growth during the study period.

Geographically, North America and Europe dominates the global market for trigeminal neuralgia therapeutics due to increased awareness among people about trigeminal neuralgia. However Asia-Pacific accounted as an emerging market in trigeminal neuralgia therapeutics owing to its large number of population. RoW is considered as an untapped market in trigeminal neuralgia therapeutics.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/5759

Various key players contributing to the global trigeminal neuralgia therapeutics market comprises Abbott Laboratories, Beckman Coulter/Danaher, bioMerieux, Bio-Rad Laboratories, Inc., Bio-Rad, Life Technology, Novartis Diagnostics and Ortho-Clinical Diagnostics.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Trigeminal Neuralgia (TN) Therapeutics Market here

News-ID: 485188 • Views: 262

More Releases from Persistence Market Research Pvt. Ltd

Electronic Specialty Gases Market is likely to surpass US$ 15 Billion by the end …
Electronic Specialty Gases Market The Global electronic specialty gases market was valued to be ~US$ 11 Billion in 2020 and is expected to exceed ~US$ 15 Billion by the end of 2030. The global electronic specialty gases market is projected to grow at a CAGR of ~3% during 2020-2030, and is estimated to reach a global value of ~US$ 15 Billion by the end of 2030. The electronic specialty gases market is
Industrial Explosives Market is slated to be worth US$ 22.4 Billion in the year …
Industrial Explosives Market The global market of industrial explosives is estimated to reach a valuation of US$ 12.3 Billion in 2023. The industrial explosives demand is anticipated to witness a growth rate of 6.2% over the forecast period of 2023 and 2033 in terms of value. The market is anticipated to top a revenue of US$ 22.4 Billion by the end of the forecast period. The introduction of innovative formulations of explosives
Industrial Catalyst Market Sales to Top US$ 31 Billion by the end of 2033
Industrial Catalyst Market The global Industrial Catalyst Market is worth more than US$ 21.6 Billion at present. The Industrial Catalyst market value is projected to increase at a CAGR of around 3.7% during 2023 - 2033. the Industrial Catalyst Market is projected to reach a revenue of US$ 31 Billion by the end of  2033. The global demand is being fueled by a huge increase in the usage of petroleum products and increased
Cold Insulation Materials Market to Reach a Revenue of Around US$ 12.65 Billion …
Cold Insulation Materials Market The global cold insulation materials market was valued at US$ 6.52 Billion in 2021. Worldwide consumption of cold insulation materials is projected to increase at 5.8% CAGR between 2022 and 2032. and reach US$ 12.65 Billion by the end of 2032. The market for cold insulation materials in the U.S. is set to expand at 6.2% CAGR over the decade. Together, Japan and S. Korea are estimated to

All 5 Releases


More Releases for Trigeminal

Trigeminal Neuralgia - Drug Pipeline Landscape, 2022
Trigeminal Neuralgia (TN), also known as tic douloureux, is a condition that causes painful sensations similar to an electric shock on one side of the face. The pain typically involves the lower face and jaw, although sometimes it affects the area around the nose and above the eye. There are two types of TN primary and secondary. Primary trigeminal Neuralgia has been linked to the compression of the nerve. Trigeminal Neuralgia
Trigeminal Neuralgia Treatment Market to Witness Robust Expansion by 2024
LP INFORMATION offers a latest published report on Trigeminal Neuralgia Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Trigeminal Neuralgia Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.
Trigeminal Neuralgia Treatment Market Opportunity Analysis, to 2026
Trigeminal neuralgia (TN), also known as tic douloureux, is a chronic pain disorder that affects the fifth cranial or trigeminal nerve. It causes inflammatory conditions due to systemic diseases including Lyme disease, sarcoidosis, and multiple sclerosis. There is also an association with collagen vascular diseases including systemic lupus erythematosus and scleroderma. The condition is treated on an outpatient basis, except till neurosurgical intervention is required. Its management must be customized
Trigeminal Neuralgia Treatment Market - Global Industry Insights, 2026
Trigeminal neuralgia (TN), also known as tic douloureux, is a chronic pain disorder that affects the fifth cranial or trigeminal nerve. It causes inflammatory conditions due to systemic diseases including Lyme disease, sarcoidosis, and multiple sclerosis. There is also an association with collagen vascular diseases including systemic lupus erythematosus and scleroderma. The condition is treated on an outpatient basis, except till neurosurgical intervention is required. Its management must be customized
Trigeminal Neuralgia - Pipeline Review, H1 2018
"The Report Trigeminal Neuralgia - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Trigeminal Neuralgia Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Trigeminal Neuralgia - Pipeline Review, H1 2018, provides an overview of the Trigeminal Neuralgia (Central Nervous System) pipeline landscape. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581021 Trigeminal neuralgia is a chronic pain
Trigeminal Neuralgia Market Rugged Expansion Foreseen by 2021
Trigeminal neuralgia occurs when the functioning of the trigeminal nerve is disrupted due to damage of the nerve. Trigeminal neuralgia is a chronic condition resulting in intense and extreme pain in the face and is more common among females. The incident represents electrical shock-like feeling and lasts from few seconds to minutes. The etiology of trigeminal neuralgia includes compression of blood vessels, degeneration of arteries, myelin sheath infiltration and idiopathic. To